Koninklijke Philips Other Long-Term Assets 2010-2024 | PHG

Koninklijke Philips other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Koninklijke Philips other long-term assets for the quarter ending September 30, 2024 were $0.781B, a 4.34% increase year-over-year.
  • Koninklijke Philips other long-term assets for 2024 were $0.136B, a 82.38% decline from 2023.
  • Koninklijke Philips other long-term assets for 2023 were $0.774B, a 3.1% decline from 2022.
  • Koninklijke Philips other long-term assets for 2022 were $0.799B, a 11.06% decline from 2021.
Koninklijke Philips Annual Other Long-Term Assets
(Millions of US $)
2024 $136
2023 $774
2022 $799
2021 $898
2020 $573
2019 $330
2018 $481
2017 $748
2016 $473
2015 $618
2014 $706
2013 $743
2012 $827
2011 $758
2010 $853
2009 $3,234
Koninklijke Philips Quarterly Other Long-Term Assets
(Millions of US $)
2024-06-30 $781
2023-06-30 $789
2023-03-31
2022-06-30 $825
2021-06-30 $748
2020-06-30 $492
2019-06-30 $428
2018-06-30 $722
2017-06-30 $842
2016-12-31 $473
2016-09-30 $487
2016-06-30 $496
2016-03-31 $558
2015-12-31 $618
2015-09-30 $607
2015-06-30 $649
2015-03-31 $678
2014-12-31 $706
2014-09-30 $698
2014-06-30 $683
2014-03-31 $746
2013-12-31 $743
2013-09-30 $878
2013-06-30 $833
2013-03-31 $857
2012-12-31 $1,053
2012-09-30 $990
2012-06-30 $1,029
2012-03-31 $1,012
2011-12-31 $758
2011-09-30 $1,002
2011-06-30 $977
2011-03-31 $812
2010-12-31 $853
2010-09-30 $3,059
2010-06-30 $3,295
2010-03-31 $3,534
2009-12-31 $3,234
2009-09-30 $1,531
2009-06-30 $1,309
2009-03-31 $3,730
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.192B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $227.162B 27.40
Boston Scientific (BSX) United States $140.689B 37.90
Stryker (SYK) United States $132.255B 28.42
EssilorLuxottica (ESLOY) France $128.431B 0.00
Medtronic (MDT) Ireland $105.938B 15.47
Lonza Group Ag (LZAGY) Switzerland $47.424B 0.00
Haleon (HLN) United Kingdom $46.151B 26.20
ResMed (RMD) United States $31.269B 24.08
Agilent Technologies (A) United States $29.217B 19.30
GE HealthCare Technologies (GEHC) United States $28.556B 13.89
Terumo (TRUMY) Japan $28.160B 0.00
Zimmer Biomet Holdings (ZBH) United States $19.373B 12.24
Insulet (PODD) United States $17.332B 74.11
Baxter (BAX) United States $14.818B 10.66
Smith & Nephew SNATS (SNN) United Kingdom $11.356B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Lantheus Holdings (LNTH) United States $6.938B 17.06
Bio-Rad Laboratories (BIO) United States $6.672B 23.10
Demant (WILYY) Denmark $6.644B 0.00
Prestige Consumer Healthcare (PBH) United States $3.977B 18.98
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.455B 9.89
ICU Medical (ICUI) United States $3.400B 29.07
Haemonetics (HAE) United States $2.872B 13.52
Envista Holdings (NVST) United States $2.614B 20.80
GN Store Nord (GNNDY) Denmark $2.188B 14.75
LeMaitre Vascular (LMAT) United States $1.946B 44.47
QuidelOrtho (QDEL) United States $1.698B 14.22
AtriCure (ATRC) United States $1.565B 0.00
Kestra Medical Technologies (KMTS) United States $1.214B 0.00
Green Thumb Industries (GTBIF) United States $1.189B 18.67
AdaptHealth (AHCO) United States $1.051B 10.12
BioLife Solutions (BLFS) United States $1.041B 0.00
InMode (INMD) Israel $1.038B 8.67
Neogen (NEOG) United States $0.953B 12.19
Phibro Animal Health (PAHC) United States $0.700B 10.74
Evolus (EOLS) United States $0.686B 0.00
Curaleaf Holdings (CURLF) Canada $0.649B 0.00
Valneva SE (VALN) France $0.552B 0.00
Owens & Minor (OMI) United States $0.535B 4.56
CeriBell (CBLL) United States $0.532B 0.00
Capricor Therapeutics (CAPR) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.450B 0.00
Surmodics (SRDX) United States $0.394B 0.00
Omeros (OMER) United States $0.394B 0.00
SNDL (SNDL) Canada $0.368B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Cresco Labs (CRLBF) United States $0.328B 0.00
VAREX IMAGING (VREX) United States $0.302B 13.07
Viemed Healthcare (VMD) United States $0.262B 23.68
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 15.65
Sanuwave Health (SNWV) United States $0.256B 0.00
Verano Holdings (VRNOF) United States $0.251B 0.00
Aurora Cannabis (ACB) Canada $0.250B 44.40
Cerus (CERS) United States $0.242B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Quanterix (QTRX) United States $0.200B 0.00
Canopy Growth (CGC) Canada $0.189B 0.00
High Tide (HITI) Canada $0.187B 0.00
Biote (BTMD) United States $0.181B 4.12
TriSalus Life Sciences (TLSI) United States $0.175B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.24
Brainsway (BWAY) Israel $0.155B 48.47
Jin Medical (ZJYL) China $0.147B 0.00
Organigram Global (OGI) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.123B 15.42
Agape ATP (ATPC) $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
TerrAscend (TSNDF) Canada $0.083B 0.00
Exagen (XGN) United States $0.080B 0.00
MacroGenics (MGNX) United States $0.079B 0.00
Veru (VERU) United States $0.078B 0.00
Fonar (FONR) United States $0.076B 10.65
Zynex (ZYXI) United States $0.066B 24.22
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.063B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
United-Guardian (UG) United States $0.038B 11.61
Apyx Medical (APYX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.036B 0.00
Rockwell Medical (RMTI) United States $0.035B 51.50
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.010B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00